These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 28119104)

  • 41. Population pharmacokinetics of S(-)-carvedilol in healthy volunteers after administration of the immediate-release (IR) and the new controlled-release (CR) dosage forms of the racemate.
    Othman AA; Tenero DM; Boyle DA; Eddington ND; Fossler MJ
    AAPS J; 2007 Jun; 9(2):E208-18. PubMed ID: 17614362
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cationic Polymeric Nanocapsules as a Strategy to Target Dexamethasone to Viable Epidermis: Skin Penetration and Permeation Studies.
    Beber TC; de Andrade DF; Chaves Pdos S; Pohlmann AR; Guterres SS; Beck RC
    J Nanosci Nanotechnol; 2016 Feb; 16(2):1331-8. PubMed ID: 27433583
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fabrication of novel GMO/Eudragit E100 nanostructures for enhancing oral bioavailability of carvedilol.
    Patil SS; Roy K; Choudhary B; Mahadik KR
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1300-7. PubMed ID: 26651381
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel chitosan-functionalized spherical nanosilica matrix as an oral sustained drug delivery system for poorly water-soluble drug carvedilol.
    Sun L; Wang Y; Jiang T; Zheng X; Zhang J; Sun J; Sun C; Wang S
    ACS Appl Mater Interfaces; 2013 Jan; 5(1):103-13. PubMed ID: 23237208
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amorphous solid dispersions of carvedilol along with pH-modifiers improved pharmacokinetic properties under hypochlorhydoria.
    Halder S; Tabata A; Seto Y; Sato H; Onoue S
    Biopharm Drug Dispos; 2018 Apr; 39(4):232-242. PubMed ID: 29607517
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Controlled release of raloxifene by nanoencapsulation: effect on in vitro antiproliferative activity of human breast cancer cells.
    Fontana MC; Beckenkamp A; Buffon A; Beck RC
    Int J Nanomedicine; 2014; 9():2979-91. PubMed ID: 24971009
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anticancer properties of lipid and poly(ε-caprolactone) nanocapsules loaded with ferrocenyl-tamoxifen derivatives.
    Najlaoui F; Pigeon P; Aroui S; Pezet M; Sancey L; Marrakchi N; Rhouma A; Jaouen G; De Waard M; Busser B; Gibaud S
    J Pharm Pharmacol; 2018 Nov; 70(11):1474-1484. PubMed ID: 30141195
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prednisolone-loaded nanocapsules as ocular drug delivery system: development, in vitro drug release and eye toxicity.
    Katzer T; Chaves P; Bernardi A; Pohlmann A; Guterres SS; Ruver Beck RC
    J Microencapsul; 2014; 31(6):519-28. PubMed ID: 24697184
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nanoencapsulation in lipid-core nanocapsules controls mometasone furoate skin permeability rate and its penetration to the deeper skin layers.
    Melero A; Ferreira Ourique A; Stanisçuaski Guterres S; Raffin Pohlmann A; Lehr CM; Ruver Beck RC; Schaefer U
    Skin Pharmacol Physiol; 2014; 27(4):217. PubMed ID: 24751514
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Carvedilol-loaded mucoadhesive buccal tablets: influence of various mucoadhesive polymers on drug release behavior.
    Tamilvanan S; Bangale GS; Ananthi JJ; Sivakumar V; Vinothapooshan G; Palanivelu M; Viswanathan MB
    PDA J Pharm Sci Technol; 2009; 63(3):196-206. PubMed ID: 20069792
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nanoemulsion system for the transdermal delivery of a poorly soluble cardiovascular drug.
    Dixit N; Kohli K; Baboota S
    PDA J Pharm Sci Technol; 2008; 62(1):46-55. PubMed ID: 18402367
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel lectin-modified poly(ethylene-co-vinyl acetate) mucoadhesive nanoparticles of carvedilol: preparation and in vitro optimization using a two-level factorial design.
    Varshosaz J; Moazen E
    Pharm Dev Technol; 2014 Aug; 19(5):605-17. PubMed ID: 23937559
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 3D printed tablets loaded with polymeric nanocapsules: An innovative approach to produce customized drug delivery systems.
    Beck RCR; Chaves PS; Goyanes A; Vukosavljevic B; Buanz A; Windbergs M; Basit AW; Gaisford S
    Int J Pharm; 2017 Aug; 528(1-2):268-279. PubMed ID: 28583328
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development, Optimization, and Evaluation of Carvedilol-Loaded Solid Lipid Nanoparticles for Intranasal Drug Delivery.
    Aboud HM; El Komy MH; Ali AA; El Menshawe SF; Abd Elbary A
    AAPS PharmSciTech; 2016 Dec; 17(6):1353-1365. PubMed ID: 26743643
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the pharmacokinetic properties of bisoprolol and carvedilol in healthy dogs.
    Beddies G; Fox PR; Papich MD; Kanikanti VR; Krebber R; Keene BW
    Am J Vet Res; 2008 Dec; 69(12):1659-63. PubMed ID: 19046015
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimization of Curcuma Oil/Quinine-Loaded Nanocapsules for Malaria Treatment.
    Gomes GS; Maciel TR; Piegas EM; Michels LR; Colomé LM; Freddo RJ; Ávila DS; Gundel A; Haas SE
    AAPS PharmSciTech; 2018 Feb; 19(2):551-564. PubMed ID: 28875471
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nanosuspension based in situ gelling nasal spray of carvedilol: development, in vitro and in vivo characterization.
    Saindane NS; Pagar KP; Vavia PR
    AAPS PharmSciTech; 2013 Mar; 14(1):189-99. PubMed ID: 23255198
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of photodynamic activity, photostability and in vitro drug release of zinc phthalocyanine-loaded nanocapsules.
    de Souza TD; Ziembowicz FI; Müller DF; Lauermann SC; Kloster CL; Santos RC; Lopes LQ; Ourique AF; Machado G; Villetti MA
    Eur J Pharm Sci; 2016 Feb; 83():88-98. PubMed ID: 26678154
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers.
    Abdel-Mottaleb MM; Neumann D; Lamprecht A
    Eur J Pharm Biopharm; 2011 Sep; 79(1):36-42. PubMed ID: 21558002
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aloin delivery on buccal mucosa: ex vivo studies and design of a new locoregional dosing system.
    De Caro V; Scaturro AL; Di Prima G; Avellone G; Sutera FM; Di Fede O; Campisi G; Giannola LI
    Drug Dev Ind Pharm; 2015; 41(9):1541-7. PubMed ID: 25311426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.